UNSPSC 51372306: Hydroxypethidine

This classification denotes an opioid receptor agonist with the molecular formula C15H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W1J43H2B3K, chemically known as 4-piperidinecarboxylic acid, 4-(m-hydroxyphenyl)-1-methyl-, ethyl ester but generally known as hydroxypethidine, which bears US NIH Compound Identifier 61120. European Medicines Agency schedules Hydroxypethidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08079MIG.

UNSPSC 51372306 Hydroxypethidine is a Commodity code that in state and local practice captures pharmaceutical procurement for emergency medical response and harm-reduction programs. State and local governments soliciting under this code are acquiring naloxone, opioid antagonists, and related medical countermeasures for public health agencies, emergency services, and community health initiatives rather than the specific pharmaceutical named in the code taxonomy.

Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement required electronic submission through the county's e-Procurement Portal, with a response deadline of July 26, 2023 at 2:00 pm, and included a two-year initial term with one-year renewal option. Vendors were required to provide unit costs for each line item, maintain drug-free workplace and E-Verify compliance, carry workers' compensation and commercial general liability insurance, and absorb all shipping and delivery costs in their bid. The contract was potentially funded through FEMA, introducing federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. The source provides only a single recent opportunity under this code; geographic activity is limited to Florida based on available records.